BPC-157: what the research shows
A popular “healing” peptide with lots of animal research behind it, and almost no proper studies in people.
Also known as Body Protection Compound-157
At a glance
Not approved anywhere, and banned in sport by the World Anti-Doping Agency (WADA). In 2026 the FDA took it off a list of risky compounding ingredients, but that is not an approval.
Step 1 of 5: Cells
Step 2 of 5: Animals
Step 3 of 5: Small human studies
Step 4 of 5: Large trials
Step 5 of 5: Approved medicine
What is BPC-157?
BPC-157 is a lab-made chain of 15 amino acids, based on a protein found in stomach juice. It became famous in sports and “biohacking” circles as a healing aid.
How does BPC-157 work?
Animal studies suggest it may help new blood vessels grow and help tissues repair. How, or whether, it works in people is not known.
What does the research show?
2025 systematic review of BPC-157 research on muscle, tendon, ligament and bone injuries, covering studies from 1993 to 2024
Studies in animals
Studies in people
In the animal studies, injured muscles, tendons, ligaments and bones healed better. The review found no safety data from people.
Source: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review · Vasireddi et al. · HSS Journal · 2025
One small look-back study · 12 people with long-term knee pain · no comparison group
7 of 12
Without a comparison group, it can’t show whether BPC-157 caused the relief.
Source: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review · Vasireddi et al. · HSS Journal · 2025
- Dozens of studies in rats and mice report faster healing of tendons, muscles, ligaments, bones and the gut.
- A 2025 review for sports medicine found the animal results encouraging, but very little evidence in humans.
- The FDA’s July 2026 meeting agenda covered BPC-157 for the bowel disease ulcerative colitis as a possible compounding ingredient. Advisory committee recommendations are non-binding and are not drug approval.
What we don't know yet
- Whether the healing seen in animals happens in people. There are no controlled trials in people.
- Its side effects and long-term safety in people.
- How it works. Animal studies point to new blood-vessel growth and less inflammation.
Known risks and side effects
- Because it hasn’t been properly tested in people, its side effects and long-term safety are unknown.
- Products sold online are not regulated, so what’s in the vial and how pure it is can vary.
- Some doctors raise a theoretical worry: if it encourages new blood vessels, it might also help existing tumors grow. This hasn’t been studied in people.
Is BPC-157 approved?
Mostly studied in cells and animals, with little or no proper testing in people.
Not approved anywhere, and banned in sport by the World Anti-Doping Agency (WADA). In 2026 the FDA took it off a list of risky compounding ingredients, but that is not an approval.
From the community
Watch: BPC-157 and related science
Start with the compound discussion, then use the background lesson to understand its biology. Each card explains its connection. Recordings may predate later findings or regulatory changes.
Dr Brad Stanfield
Should you take BPC-157 peptides?
What the research on BPC-157 actually contains, study by study.
Brad Stanfield, MBChB, general practitioner
Discusses the compound
Discusses BPC-157 or its clinical context. Read the original studies linked here for the exact formulation, population and outcomes.
Pain Specialists Australia
BPC-157 for pain: what the evidence actually says
Two pain specialists weigh the evidence and the risks of BPC-157, TB-500, ARA-290, MOTS-c and GHK-Cu, including contamination of products sold online.
Dr Nick Christelis and Dr Bradley Lewinsohn, specialist pain medicine physicians (FFPMANZCA)
Discusses the compound
Two specialist pain physicians review the evidence for BPC-157 (from 16:08), TB-500 (24:04), ARA-290 (4:54), MOTS-c (25:51) and GHK-Cu (24:56), and the risks of unregulated products.
Khan Academy
Phagocytes and innate immunity
How part of the immune system responds to threats and contributes to inflammation.
Immune-system biology education
Related biology
Background on immune cells and inflammation for understanding BPC-157. It does not demonstrate benefits of this compound or formulation.
Sources and references
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewVasireddi et al. · HSS Journal · 2025
- FDA Pharmacy Compounding Advisory Committee, July 23–24, 2026US Food and Drug Administration · meeting page
- Bulk drug substances nominated for compounding under Section 503AUS Food and Drug Administration · updated May 14, 2026 (PDF)
VETUD Learn explains published research in plain language. It is general information, not medical advice. Talk to a doctor before starting, stopping or changing any treatment.
In the research shop
Check the catalog for related laboratory research materials. These products are separate from the approved medicines and clinical trial formulations discussed here.
Checking regional availability…
